Angelo Rosolen

4.4k total citations
82 papers, 2.5k citations indexed

About

Angelo Rosolen is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Angelo Rosolen has authored 82 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pathology and Forensic Medicine, 29 papers in Pulmonary and Respiratory Medicine and 24 papers in Molecular Biology. Recurrent topics in Angelo Rosolen's work include Lymphoma Diagnosis and Treatment (30 papers), Sarcoma Diagnosis and Treatment (23 papers) and Acute Lymphoblastic Leukemia research (17 papers). Angelo Rosolen is often cited by papers focused on Lymphoma Diagnosis and Treatment (30 papers), Sarcoma Diagnosis and Treatment (23 papers) and Acute Lymphoblastic Leukemia research (17 papers). Angelo Rosolen collaborates with scholars based in Italy, United States and France. Angelo Rosolen's co-authors include Paolo Bonvini, Marta Pillon, Alfred Reiter, Rita Alaggio, Lara Mussolin, Modesto Carli, Vito Ninfo, E. Frascella, Emanuele S.G. dʼAmore and Denise Williams and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Angelo Rosolen

82 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angelo Rosolen Italy 31 1.0k 907 745 681 413 82 2.5k
Anna Marina Liberati Italy 31 1.3k 1.3× 1.1k 1.2× 332 0.4× 1.9k 2.9× 397 1.0× 148 3.8k
Felice Pasini Italy 35 459 0.4× 751 0.8× 1.5k 2.0× 1.6k 2.4× 437 1.1× 119 3.5k
Nozomi Niitsu Japan 28 1.5k 1.4× 799 0.9× 156 0.2× 969 1.4× 556 1.3× 120 2.5k
Jonathan Shamash United Kingdom 30 326 0.3× 698 0.8× 1.5k 2.0× 981 1.4× 301 0.7× 141 3.1k
Ye Guo China 28 412 0.4× 684 0.8× 393 0.5× 1.0k 1.5× 78 0.2× 217 2.3k
Dusan Kotasek Australia 28 371 0.4× 448 0.5× 542 0.7× 1.2k 1.7× 125 0.3× 104 2.3k
Seiichi Tamai Japan 28 476 0.5× 840 0.9× 662 0.9× 720 1.1× 81 0.2× 118 2.7k
Theodoros P. Vassilakopoulos Greece 26 1.6k 1.6× 540 0.6× 316 0.4× 1.6k 2.4× 445 1.1× 167 3.1k
Luisella Righi Italy 35 367 0.4× 582 0.6× 1.5k 2.0× 1.9k 2.8× 648 1.6× 134 3.5k
R. Osieka Germany 28 412 0.4× 1.1k 1.2× 320 0.4× 693 1.0× 114 0.3× 89 2.4k

Countries citing papers authored by Angelo Rosolen

Since Specialization
Citations

This map shows the geographic impact of Angelo Rosolen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelo Rosolen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelo Rosolen more than expected).

Fields of papers citing papers by Angelo Rosolen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelo Rosolen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelo Rosolen. The network helps show where Angelo Rosolen may publish in the future.

Co-authorship network of co-authors of Angelo Rosolen

This figure shows the co-authorship network connecting the top 25 collaborators of Angelo Rosolen. A scholar is included among the top collaborators of Angelo Rosolen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angelo Rosolen. Angelo Rosolen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lovisa, Federica, Giorgio Cozza, Alberto Cuzzolin, et al.. (2015). ALK Kinase Domain Mutations in Primary Anaplastic Large Cell Lymphoma: Consequences on NPM-ALK Activity and Sensitivity to Tyrosine Kinase Inhibitors. PLoS ONE. 10(4). e0121378–e0121378. 6 indexed citations
2.
Tombolan, Lucia, Matteo Zampini, Silvia Casara, et al.. (2015). MicroRNA-27a Contributes to Rhabdomyosarcoma Cell Proliferation by Suppressing RARA and RXRA. PLoS ONE. 10(4). e0125171–e0125171. 25 indexed citations
3.
Zin, Angelica, Roberta Bertorelle, Patrizia Dall’Igna, et al.. (2014). Epithelioid Rhabdomyosarcoma. The American Journal of Surgical Pathology. 38(2). 273–278. 22 indexed citations
4.
Mussolin, Lara, Roberta Burnelli, Marta Pillon, et al.. (2013). Plasma Cell-Free DNA in Paediatric Lymphomas. Journal of Cancer. 4(4). 323–329. 40 indexed citations
5.
Bonvini, Paolo, et al.. (2012). Effect of inhibition of the Ubiquitin-Proteasome System and Hsp90 on growth and survival of Rhabdomyosarcoma cells in vitro. BMC Cancer. 12(1). 233–233. 18 indexed citations
6.
Tombolan, Lucia, Francesca Orso, Vincenza Guzzardo, et al.. (2011). High IGFBP2 Expression Correlates with Tumor Severity in Pediatric Rhabdomyosarcoma. American Journal Of Pathology. 179(5). 2611–2624. 29 indexed citations
7.
Mastrangelo, Stefano, Antonio Ruggiero, Maria Scalzone, et al.. (2011). Treatment of pharyngeal non‐Hodgkin lymphoma in a patient with Wiskott‐Aldrich syndrome. Pediatric Blood & Cancer. 59(2). 318–319. 11 indexed citations
8.
Alaggio, Rita, et al.. (2009). Pediatric extra-renal rhabdoid tumors with unusual morphology: A diagnostic pitfall for small biopsies. Pathology - Research and Practice. 205(7). 451–457. 17 indexed citations
9.
Lovisa, Federica, Lara Mussolin, Lilia Corral, et al.. (2009). IGH and IGK gene rearrangements as PCR targets for pediatric Burkitt's lymphoma and mature B-ALL MRD analysis. Laboratory Investigation. 89(10). 1182–1186. 13 indexed citations
10.
Colombatti, Raffaella, et al.. (2008). Successful Treatment of Severe Iatrogenic Calcinosis Cutis with Intravenous Sodium Thiosulfate in a Child Affected by T‐Acute Lymphoblastic Leukemia. Pediatric Dermatology. 26(3). 311–315. 18 indexed citations
11.
Cerutti, Elisa, Maria Francesca Campagnoli, Massimo Ferretti, et al.. (2007). Co-inherited mutations of Fas and caspase-10 in development of the autoimmune lymphoproliferative syndrome. BMC Immunology. 8(1). 28–28. 28 indexed citations
12.
Molena, Béatrice, Anna Maria Brunati, Modesto Carli, et al.. (2007). Functional VEGF and VEGF receptors are expressed in human medulloblastomas. Neuro-Oncology. 9(4). 384–392. 51 indexed citations
13.
Alaggio, Rita, Giulio Andrea Zanazzo, Alberto Garaventa, et al.. (2006). Results of a prospective minimal disseminated disease study in human rhabdomyosarcoma using three different molecular markers. Cancer. 106(8). 1766–1775. 27 indexed citations
14.
Romualdi, Chiara, Cristiano De Pittà, Lucia Tombolan, et al.. (2006). Defining the gene expression signature of rhabdomyosarcoma by meta-analysis. BMC Genomics. 7(1). 287–287. 33 indexed citations
15.
Rosolen, Angelo, Marta Pillon, Alberto Garaventa, et al.. (2005). Anaplastic large cell lymphoma treated with a leukemia‐like therapy. Cancer. 104(10). 2133–2140. 58 indexed citations
16.
Kronnie, Geertruy te, Fabio Timeus, Andrea Rinaldi, et al.. (2004). Imatinib mesylate (STI571) interference with growth of neuroectodermal tumour cell lines does not critically involve c-Kit inhibition. International Journal of Molecular Medicine. 14(3). 373–82. 17 indexed citations
17.
Pession, Andrea, Glenda Canderan, Maurizio Bendandi, et al.. (2003). Non-Radiolabelled PCR Consensus Primers and Automatic Sequencing Enable Rapid Identification of Tumor-Specific VHCDR3 in Aggressive B-Cell Malignancies. Leukemia & lymphoma. 44(9). 1597–1601. 2 indexed citations
18.
Frascella, E., Elisabetta Lenzini, Beat W. Schäfer, et al.. (2000). Concomitant Amplif ication and Expression of PAX7-FKHR and MYCN in a Human Rhabdomyosarcoma Cell Line Carrying a Cryptic t(1;13)(p36;q14). Cancer Genetics and Cytogenetics. 121(2). 139–145. 19 indexed citations
19.
Frascella, E., Luisa Toffolatti, & Angelo Rosolen. (1998). Normal and Rearranged PAX3 Expression in Human Rhabdomyosarcoma. Cancer Genetics and Cytogenetics. 102(2). 104–109. 29 indexed citations
20.
Smith, Malcolm A., Paul M. Sondel, Andrea Gillespie, et al.. (1992). A Phase I Study of Interleukin-2 in Children with Cancer. Journal of Pediatric Hematology/Oncology. 14(4). 305–311. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Marina Liberati Breakdown of academic impact, for papers by Felice Pasini Breakdown of academic impact, for papers by Nozomi Niitsu Breakdown of academic impact, for papers by Jonathan Shamash Breakdown of academic impact, for papers by Ye Guo Breakdown of academic impact, for papers by Dusan Kotasek Breakdown of academic impact, for papers by Seiichi Tamai Breakdown of academic impact, for papers by Theodoros P. Vassilakopoulos Breakdown of academic impact, for papers by Luisella Righi Breakdown of academic impact, for papers by R. Osieka
Rankless by CCL
2026